HMC and Boehringer Ingelheim Partner to Boost Medical Innovation in Qatar

Hamad Medical Corporation (HMC) entered into a formal agreement with Boehringer Ingelheim to advance medical development within the country. This Memorandum of Understanding (MoU) establishes a collaborative framework between the Qatari healthcare provider and the global biopharmaceutical leader to foster clinical research, healthcare innovation, and workforce development. By aligning their efforts, the organizations aim to […]

The post HMC and Boehringer Ingelheim Partner to Boost Medical Innovation in Qatar first appeared on HHM Global | B2B Online Platform & Magazine.